Saraca asoca (Ashoka) flower extract improves scopolamine-impaired task performance in mice; changes in brain cholinesterase activity and oxidative stress markers
Year: 2026
Type: preprint
Abstract: Cognitive impairment and anxiety often coexist, and cholinergic dysfunction and oxidative stress are implicated in both. The current study aimed to evaluate the ethanolic flower extract of Saraca asoca (SAF) against scopolamine-induced impairment of task performance in Swiss albino mice, together with the brain cholinesterase and oxidative changes that accompany it. SAF contained 90.94 ± 0.75 mg gallic acid equivalents/g and 51.54 ± 0.78 mg quercetin equivalents/g, was fingerprinted by LC–DAD–ESI–TOF–MS, and scavenged DPPH radicals with an IC₅₀ of 62.7 µg/mL as opposed to 34.8 µg/mL for vitamin E. Mice received SAF (50, 100, and 250 mg/kg, p.o.) for 14 days, with scopolamine (0.4 mg/kg, i.p.) before passive avoidance, novel object recognition, and Y-maze tests. A second cohort received one scopolamine injection on day 14 for brain biochemistry. Scopolamine shortened retention latency about 3.1-fold and lowered the discrimination index about 3.0-fold; it also raised brain cholinesterase activity and malondialdehyde (MDA) and lowered catalase about 2.5-fold. SAF at 100 and 250 mg/kg improved performance in all three tasks and lowered cholinesterase activity and MDA, and all doses partly restored catalase. These effects were confirmed after false discovery rate correction. In a third cohort, SAF increased open-arm time and social interaction, but these anxiety data are exploratory because no locomotor control or usable diazepam comparison was available. SAF thus improved scopolamine-impaired task performance, alongside lower brain cholinesterase activity and oxidative stress.
Source: Research Square
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236808942
